IgA vasculitis (Henoch-Schönlein purpura) in children: initial tests and renal monitoring
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
At diagnosis: initial tests
- Measure blood pressure and look for oedema.
Laboratory tests
- FBC with platelets (purpura with normal platelets)
- Serum creatinine with eGFR, paediatric formula (if dipstick abnormal or moderate to severe form)if needednon-French guidelineThe IPNA asks for GFR calculation in every affected child [1] and the American AAFP review for initial kidney tests [2]. The Australian guide from the Royal Children's Hospital Melbourne reserves blood tests for moderate to severe forms [3].
- Serum albumin (if dipstick abnormal or moderate to severe form)if needednon-French guidelineThe IPNA asks for serum albumin in every affected child [1], as does the American AAFP review [2]. The Australian guide from the Royal Children's Hospital Melbourne reserves blood tests for moderate to severe forms [3].
Urine tests (first morning urine)
- Urine dipstick (haematuria, proteinuria)
- Urine protein:creatinine ratio (spot sample) (if proteinuria on the dipstick)if needednon-French guidelineThe IPNA asks for proteinuria to be quantified in every affected child [1]. The Australian guide from the Royal Children's Hospital Melbourne asks for this ratio only if the dipstick shows proteinuria [3].
- PTif needednon-French guidelineThe American AAFP review (2020) includes a coagulation screen in the initial tests, to rule out a coagulopathy [2] (expert opinion). The Australian guide from the Royal Children's Hospital Melbourne (2026) lists it among the further tests guided by the manifestations or differential diagnoses [3]. The British guidelines (UK Kidney Association, 2022) provide at diagnosis only for urinalysis and blood pressure [4].
- aPTTif needednon-French guidelineThe American AAFP review (2020) includes a coagulation screen in the initial tests, to rule out a coagulopathy [2] (expert opinion). The Australian guide from the Royal Children's Hospital Melbourne (2026) lists it among the further tests guided by the manifestations or differential diagnoses [3]. The British guidelines (UK Kidney Association, 2022) provide at diagnosis only for urinalysis and blood pressure [4].
No renal involvement at onset: monthly monitoring for 6 months
Every month for at least 6 months, even if the urine remains normal
- Blood pressure and look for oedema at every check.
- Urine dipstick on first morning urine
- Urine protein:creatinine ratio on first morning urine (if proteinuria on the dipstick)if needednon-French guidelineThe IPNA asks for the initial assessment, including quantification of proteinuria, to be repeated every month [1]. The British guidelines, KDIGO and the Melbourne guide speak of urinalysis or urine monitoring without asking for this ratio routinely [3,4,5].
- Serum creatinine with eGFRif needednon-French guidelineThe IPNA asks for the whole initial assessment to be repeated every month (blood pressure, oedema, serum albumin, GFR, urinalysis) [1]; KDIGO mentions only monthly urine monitoring [5]. Do at least if proteinuria, haematuria, hypertension or oedema appear.
- Serum albuminif needednon-French guidelineThe IPNA asks for the whole initial assessment to be repeated every month (blood pressure, oedema, serum albumin, GFR, urinalysis) [1]; KDIGO mentions only monthly urine monitoring [5]. Do at least if proteinuria, haematuria, hypertension or oedema appear.
IgA vasculitis nephritis: follow-up shared with the paediatric nephrologist
Every month for 6 months
- Urine dipstick
- Urine protein:creatinine ratio (first morning urine)
- Serum creatinine with eGFR
Then every 3 months for 6 months, then every 6 months for at least 5 years
- Urine dipstick
- Urine protein:creatinine ratio (first morning urine)
- Serum creatinine with eGFR
Then: once a year, for life
- Urine dipstick and blood pressure (if moderate to severe kidney disease)if needednon-French guidelineThe IPNA considers lifelong annual assessment of urine and blood pressure prudent in moderate to severe forms of kidney disease [1].
Also consider
- Proteinuria treated with an ACE inhibitor or ARB? For laboratory monitoring, see the page "Starting or changing the dose of an ACE inhibitor/ARB".
Sources (6)
- Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, et al. IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol. 2025;40(2):533-69.
- Reamy BV, Servey JT, Williams PM. Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review. Am Fam Physician. 2020;102(4):229-233.
- The Royal Children's Hospital Melbourne. Clinical Practice Guidelines : IgA vasculitis. Guide approuvé par le Paediatric Improvement Collaborative (Victoria, Australie), dernière mise à jour août 2026.
- Oni L, Mulvaney S, Haigh G, et al. ; UK IgAV Clinical Practice Guideline Working Group. UK Kidney Association Clinical Practice Guidelines for the Initial Management of IgA vasculitis (Henoch Schönlein Purpura) in children and young people. Version finale de décembre 2022 (révision prévue en décembre 2027).
- Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group. KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney Int. 2025;108(4S):S1-S71.
- Ozen S, Marks SD, Brogan P, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis — the SHARE initiative. Rheumatology (Oxford). 2019;58(9):1607-1616.